StonvexLoading…
StonvexStonvexStonvexCore line items from IPI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $58.85M | $98.69M | $298.33M | $94.53M | $254.69M |
Operating Income | Not available | $6.22M | $10.66M | $3.70M | $-19.86M |
Net Income | Not available | $7.42M | $11.19M | $4.61M | $-212.84M |
EPS (Diluted) | $0.32 | $0.56 | $0.85 | $0.35 | $-16.53 |
Total Assets | Not available | $641.54M | $632.18M | $601.28M | $594.52M |
Total Liabilities | Not available | $143.34M | $140.75M | $121.82M | $120.13M |
Cash & Equivalents | Not available | $99.26M | $83.54M | $45.67M | $41.31M |
Free Cash Flow OCF − CapEx | Not available | $18.03M | $25.54M | $3.25M | $33.79M |
Shares Outstanding | Not available | 13.19M | 13.13M | 12.96M | 12.91M |